Belgium focused on ethics reforms to boost clinical trial competitiveness

EURACTIV - Belgium's health minister, Frank Vandenbroucke, has outlined the federal government's 2026 health policy priorities before the Commission on Health and Equal Opportunities, placing long‑awaited reforms to ethics committees formally on the legislative agenda. The move marks the transition from the broad commitments set out in the 2025-29 coalition accord to concrete implementation. Read more

Gloria Ghequière, Deputy Head of Cabinet to Minister Vandenbroucke [[Photo credit: Pharma.be – Forum Clinical Trials 2026]]